| http://www.w3.org/ns/prov#value | - These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission, including Part I, Item 1A of our most recent Form 10-K, and include but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for ne'/>/>SOURCE Caraco Pharmaceutical Laboratories, Ltd
|
